Dow struggles to hold onto gains amid report of disappointment in Gilead’s experimental coronavirus drug

U.S. stocks trade well off their best levels Thursday afternoon, running into some turbulence amid reports that suggested that a closely followed experimental drug that would be used to treat coronavirus delivered disappointing results in a trial. Read More...